Literature DB >> 31443925

Is it time to include cancer in cardiovascular risk prediction tools?

Anne H Blaes1, Chetan Shenoy2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31443925     DOI： 10.1016/S0140-6736(19)31886-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Cardio-Oncology Education and Training: JACC Council Perspectives.

Authors:  Jose A Alvarez-Cardona; Jordan Ray; Joseph Carver; Vlad Zaha; Richard Cheng; Eric Yang; Joshua D Mitchell; Keith Stockerl-Goldstein; Lavanya Kondapalli; Susan Dent; Anita Arnold; Sherry Ann Brown; Monica Leja; Ana Barac; Daniel J Lenihan; Joerg Herrmann
Journal:  J Am Coll Cardiol       Date:  2020-11-10       Impact factor: 24.094

Review 2.  Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Authors:  Sherry-Ann Brown; Eric H Yang; Mary Branch; Craig Beavers; Anne Blaes; Michael G Fradley; Richard K Cheng
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

3.  Icariin Protects H9c2 Rat Cardiomyoblasts from Doxorubicin-Induced Cardiotoxicity: Role of Caveolin-1 Upregulation and Enhanced Autophagic Response.

Authors:  Miriam Scicchitano; Cristina Carresi; Saverio Nucera; Stefano Ruga; Jessica Maiuolo; Roberta Macrì; Federica Scarano; Francesca Bosco; Rocco Mollace; Antonio Cardamone; Anna Rita Coppoletta; Lorenza Guarnieri; Maria Caterina Zito; Irene Bava; Luca Cariati; Marta Greco; Daniela Patrizia Foti; Ernesto Palma; Micaela Gliozzi; Vincenzo Musolino; Vincenzo Mollace
Journal:  Nutrients       Date:  2021-11-14       Impact factor: 5.717

4.  Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study.

Authors:  Laurence H Baker; Philip S Boonstra; Denise K Reinke; Erin J Peregrine Antalis; Bradley J Zebrack; Richard L Weinberg
Journal:  J Cancer Metastasis Treat       Date:  2020-08-07

5.  Longitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment.

Authors:  Guro F Giskeødegård; Torfinn S Madssen; Matteo Sangermani; Steinar Lundgren; Torgeir Wethal; Trygve Andreassen; Randi J Reidunsdatter; Tone F Bathen
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

6.  Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer.

Authors:  Atul Batra; Dropen Sheka; Shiying Kong; Winson Y Cheung
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

Review 7.  Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer.

Authors:  Renske Altena; Laila Hubbert; Narsis A Kiani; Yvonne Wengström; Jonas Bergh; Elham Hedayati
Journal:  Cardiooncology       Date:  2021-05-28

8.  Cardiovascular morbidities in postoperative colorectal cancer patients.

Authors:  Hyangkyoung Kim; In Ja Park; Youngjin Han; Tae-Won Kwon; Yong-Pil Cho
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.